Canabolabs

About

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Canabolabs' primary focus as a pharmaceutical company?

Canabolabs is an international pharmaceutical company specializing in the research and development of medicines from natural origin and the development of technologies and patents for medicinal release.

What types of diseases does Canabolabs aim to treat?

Canabolabs focuses on the treatment of chronic and malignant diseases.

When was Canabolabs founded?

Canabolabs was founded in April 2017.

What is the operational status of Canabolabs?

Canabolabs is currently inactive, having ceased operations in June 2019.

Where is Canabolabs headquartered?

Canabolabs is headquartered in Caesarea, Israel.

How many employees did Canabolabs have?

Canabolabs had between 1 and 10 employees, with an exact count of 6.

What is Canabolabs' current funding stage?

Canabolabs is in the Pre-Funding stage.

What are some of the products developed by Canabolabs?

Canabolabs developed products such as Cannabol drops, Cannabol forte, Cannabol night, Cannabol active, Cannabol Inhaler, and Cannabol comfort.

What is the primary sector for Canabolabs?

Canabolabs' primary sector is Health Tech & Life Sciences, with specializations in Pharma & Medical Biotechnology, Drugs Discovery & Development, and Medical Cannabis.

Sectors & technology

Tags